New Approaches to the Design of Platinum Antitumor Agents

  • L. Steven Hollis


In the years since the discovery of cisplatin, the search for new platinum-based antitumor agents has grown at a staggering rate. Several thousand platinum complexes have been prepared and screened in laboratories throughout the world in an effort to develop new platinum drugs with improved therapeutic properties. In many respects these efforts have been rewarded, as second generation analogs such as carboplatin are now proving to be successful clinical agents.1 However, the majority of the new compounds2 that have been identified from these studies are close relatives of cisplatin from a structural point of view and, by virtue of this fact, these agents are similar in terms of their mechanism of action.3 Consequently, clinical expectations for new platinum antitumor agents remain somewhat tempered by the narrow class of compounds that have been identified from drug discovery efforts. While basic improvements in pharmacology and toxicology have been made by altering the reactivity and lipophilicity of the cisplatin analogs, little progress has been made in altering the spectrum of activity displayed by these complexes. One approach to solving this problem is to look beyond the structural relatives of cisplatin by identifying novel materials that can be utilized as building blocks for new classes of platinum antitumor agents.


Antitumor Agent Platinum Complex Platinum Drug Drug Discovery Effort Carbodiimide Coupling 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.(a)
    Dabrowiak, J. C.; Bradner, W. T. In Progress in Medicinal Chemistry; Ellis, G. P.; West, G. B., Eds.; Elsevier: Amsterdam, 1987; Vol. 24, p 129.Google Scholar
  2. (b).
    Barnard, C. F.; Cleare, M. J.; Hydes, P. C. Chem. Brit. 1986, 22, 1001.Google Scholar
  3. (c).
    Anderson, W. K.; Quagiato, D. A.; Haugwitz, R. D.; Narayanan, V. L.; Wolpert-DeFilippes, M. K. Cancer Treat. Rep. 1986, 70, 997.PubMedGoogle Scholar
  4. (e).
    Rahman, A.; Roh, J. K.; Wolpert-DeFilippes, M. K.; Goldin, A.; Venditti, J. M.; Wolley, P. V. Cancer Res. 1988,48, 1745.PubMedGoogle Scholar
  5. 2.
    Pasini, A.; Zunino, F. Angew. Chem. Int. Ed. Engl. 1987,26, 615.CrossRefGoogle Scholar
  6. 3.(a)
    Sherman, S. E.; Lippard, S. J. Chem. Rev. 1987,87, 1153.CrossRefGoogle Scholar
  7. (b).
    Reedijk, J.; Fichtinger-Shepman, A. M. J.; van Oosterom, A. T.; van de Putte, P. Struct. Bonding 1987, 67 53.CrossRefGoogle Scholar
  8. (c).
    van der Veer, J. L.; Reedijk, J. Chem. Brit. 1988, 24, 775.Google Scholar
  9. 4.
    Cleare, M. J.; Hoeschele, J. D. Bioinorg. Chem. 1973,2, 187.CrossRefGoogle Scholar
  10. 5.
    Carter, S. K. In Platinum Coordination Complexes in Cancer Chemotherapy; Hacker, M. P.; Doyle, E. B.; Krakoff, I. H., Eds.; Martinus-Nijhoff Publishing: Boston, 1984; p 359.CrossRefGoogle Scholar
  11. 6.
    Knox, R.J.; Friedlos, F.; Lydall, D. A.; Roberts, J. J. Cancer Res. 1986,46, 1972.PubMedGoogle Scholar
  12. 7.
    Hollis, L. S.; Amundsen, A. R.; Stern, E. W. J. Med. Chem. 1989,32, 128.PubMedCrossRefGoogle Scholar
  13. 8.
    Macquet, J. P.; Butour, J.-L. J. Natl. Cancer Inst. 1983,70, 889.Google Scholar
  14. 9.
    Stillman, B. W.; Gluzman, Y. Mol. Cell. Biol. 1985, 5, 2051. 18.PubMedGoogle Scholar
  15. 10.
    Hollis, L. S.; Sundquist, W. I.; Burstyn, J. N. Heiger-Bernays, W. J.; Bellon, S. F.; Ahmed, K. J.; Amundsen, A. R.; Stern, E. W.; Lippard, S. J. Cancer Res. In press.Google Scholar
  16. 11.
    Pinto, A. L.; Lippard, S. J. Proc. Natl. Acad. Sci. USA 1985,82, 4616.PubMedCrossRefGoogle Scholar
  17. 12.
    Sundquist, W. I.; Lippard, S. J.; Stollar, B. D. Biochemistry 1986,25, 1520.PubMedCrossRefGoogle Scholar
  18. 13.
    Maron, D. M.; Ames, B. N. Mutation Res. 1983, 113. 173.PubMedCrossRefGoogle Scholar
  19. 14.
    Hollis, L. S. Unpublished results.Google Scholar
  20. 15.
    Hannan, M. A.; Al-Dakan, A. A.; Hussain, S. S.; Amer, M. H. Toxicology 1989, 55, 183.PubMedCrossRefGoogle Scholar
  21. 16.
    Lempers, E. L. M.; Bloemink, M. J.; Brouwer, Y.; Kidani, Y.; Reedijk, J. J. IInorq. Biochem. In press.Google Scholar
  22. 17.
    Hollis, L. S.; Stern, E. W. U. S. and Eur. Pat. Appl. 1989.Google Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • L. Steven Hollis
    • 1
  1. 1.Engelhard CorporationEdisonUSA

Personalised recommendations